Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host

doi:10.1016/j.coph.2013.08.006

Current Opinion in Pharmacology

Volume 13, Issue 6, December 2013, Pages 869-874

https://doi.org/10.1016/j.coph.2013.08.006 Get rights and content

Highlights

•
The relationship between colonic bacteria and the host is not commensal but mutual.
•
Bacterial fermentation products serve as the messengers in this relationship.
•
The fermentation products protect against inflammation and cancer in colon.
•
SLC5A8 is critical for bacteria–host communication only when fiber intake is low.
•
GPR109A and GPR43 are critical for the communication even with optimal fiber intake.

The mutually beneficial relationship between colonic bacteria and the host has been recognized but the molecular aspects of the relationship remain poorly understood. Dietary fiber is critical to this relationship. The short-chain fatty acids acetate, propionate and butyrate, generated by bacterial fermentation of dietary fiber, serve as messengers between colonic bacteria and the host. The beneficial effects of these bacterial metabolites in colon include, but are not limited to, suppression of inflammation and prevention of cancer. Recent studies have identified the plasma membrane transporter SLC5A8 and the cell-surface receptors GPR109A and GPR43 as essential for the biologic effects of short-chain fatty acids in colon. These three proteins coded by the host genome provide the molecular link between colonic bacteria and the host.

Introduction

The human body harbors trillions (∼10¹⁴) of microorganisms, most of them present in the large intestine, playing an important role in the health of the host. Though called ‘commensal bacteria’, the relationship between gut-associated bacteria and the host is not commensal. The term ‘commensalism’ was based on the belief that only bacteria benefit from this co-habitation while the host neither benefits nor is harmed. From what we know now, nothing can be farther from the truth. Normal bacteria in colon have profound effects on the host, including protection against enteric infections, production of vitamins, maturation of intestinal function, assistance in digestion and absorption, modulation of the mucosal immune system in the gut, and maintenance of energy homeostasis [1, 2, 3]. Thus, the term ‘mutualism’ is more justifiable than ‘commensalism’ to describe the relationship between gut bacteria and the host. The well-deserved recognition of the importance of gut bacteria to our health has been one of the hallmarks of the last decade, highlighted by the initiation of the Human Microbiome Project by the National Institutes of Health in the United States. This project has delineated the range of structural and functional diversity of the microbial communities that reside in different parts, including the large intestine, of a healthy human body [4^••]. The recent progress relating to the microbial ecology of the mammalian gut in health and disease has been hailed as one of the ten major breakthroughs of the year 2011 [5].

The health benefits of colonic bacteria are principally related to dietary fiber, which includes resistant starch and non-starch polysaccharides such as cellulose, hemicellulose, pectins, and gums. There are two classes of dietary fiber: soluble and insoluble. Most of the soluble fibers are fermentable by colonic bacteria and used as the nutrient source to support the growth of these microorganisms in the colon. It has been known for decades that the short-chain fatty acids (SCFAs: acetate, propionate, and butyrate), produced by bacterial fermentation of dietary fiber, are the mediators of the beneficial effects of colonic bacteria on the host [6, 7, 8], but the molecular mechanisms underlying the process remained poorly understood. This has changed dramatically in recent years. In this review, we summarize the recent discoveries on the role of three genes in the host genome, namely SLC5A8, GPR109A, and GPR43, as the critical determinants of the bacteria–host communication.

Section snippets

SCFAs as bacterial metabolites and their function in the colon

Most of the bacteria in the mammalian large intestine are anaerobes, which ferment dietary carbohydrates, particularly resistant starch and dietary fiber, into acetate, propionate, and butyrate. The relative proportions of these three bacterial metabolites in the colonic lumen are 6:3:1, and the total concentration is approximately 100 mm. These metabolites are readily absorbed in the colon and serve as the preferred energy substrates for colonocytes. Only small amounts of these SCFAs leave the

SLC5A8, a plasma membrane transporter, and its relevance to intracellular actions of SCFAs in colonocytes and immune cells

SLC5A8 was originally identified as a tumor suppressor that is silenced in colon cancer by DNA methylation [13]. When re-expressed in colon cancer cells, SLC5A8 causes growth arrest and apoptosis. However, the identity of the substrate that is transported by the protein was not known. How the transport function could be linked to tumor suppression also remained unclear. Studies from our laboratory showed for the first time that SLC5A8 is a Na⁺-coupled transporter for a variety of SCFAs,

GPR109A, a cell-surface G-protein-coupled receptor, and its relevance to the biologic actions of butyrate in colon

GPR109A (hydroxycarboxylic acid receptor 2 or HCA2) was first identified as a G-protein-coupled receptor that is induced by IFN-γ in macrophages [26] and thus named PUMA-G (Protein Upregulated in MAcrophages by IFN-Gamma). GPR109A in humans corresponds to PUMA-G in rodents [27]. GPR109A is expressed not only in macrophages but also in adipocytes. Two independent groups of investigators, while searching for the mechanism underlying the lipid-lowering effects of niacin, discovered that niacin

GPR43, a cell-surface G-protein-coupled receptor, and its relevance to the biologic actions of SCFAs

GPR43 (free fatty acid receptor 2; FFAR2), is also a cell-surface G-protein-coupled receptor expressed in the colon, which is activated by SCFAs, primarily acetate and propionate [33, 34]. Activation of GPR43 signaling by SCFAs plays a role in the regulation of appetite, electrolyte and fluid secretion, and inflammation [35, 36, 37••, 38, 39]. Gpr43^−/− mice show reduced inflammatory responses against infection with the pathogenic bacterium C. rodentium while activation of the receptor with

Influence of gut bacteria on the intestinal expression of Slc5a8 and Gpr109a

Since butyrate, a bacterial fermentation product, is the substrate for SLC5A8 and agonist for GPR109A, we asked: Do gut bacteria influence the expression of SLC5A8 and GPR109A in colon? We addressed this question by comparing the expression of these two genes in the intestinal tract between conventional mice with normal bacteria in colon and germ-free mice with no bacteria in the intestine or anywhere else in the body [31^••]. Slc5a8 mRNA and Gpr109a mRNA levels in colon and ileum were reduced

Dietary fiber content and its relationship to the functions of SLC5A8, GPR109A, and GPR43

Our hypothesis is that SLC5A8, GPR109A, and GPR43 are obligatory for the beneficial effects of SCFAs in colon. Knockout mouse models with deletion of Slc5a8, Gpr109a, and Gpr43 would be useful to test this hypothesis. Slc5a8^−/− mice have been generated recently [41]. Surprisingly, treatment of Slc5a8^−/− mice with carcinogens or crossing these mice with Apc^Min/+ mice did not show any difference in tumor formation. Even though these findings seem to question the tumor-suppressive role of Slc5a8,

Nutritional and pharmacological implications

Optimal concentrations of SCFAs in the colonic lumen are essential for maintenance of colonic health. The concentrations of SCFAs in the colon can be reduced under various conditions such as intake of low dietary fiber and chronic use of antibiotics. Generation of SCFAs in colon can be optimized with nutritional interventions such as intake of appropriate prebiotics and probiotics. A recent study has shown that supplementation of the probiotic Lactobacillus GG and the butyrate ester tributyrin

Conclusions

On the basis of our current knowledge, we conclude that firstly the anti-inflammatory and tumor-suppressive functions of the high-affinity butyrate/propionate transporter SLC5A8 are dispensable under conditions of high-fiber intake but not dispensable under conditions of low-fiber intake, secondly the anti-inflammatory and tumor-suppressive signaling via the low-affinity SCFA receptors GPR109A and GPR43 is optimal only when the dietary fiber content is high but becomes suboptimal under

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as:

• of special interest
•• of outstanding interest

References (44)

E. Gopal et al.
Expression of slc5a8 in kidney and its role in Na⁺-coupled transport of lactate
J Biol Chem
(2004)
M.J. Coady et al.
The human tumour suppressor gene SLC5A8 expresses a Na⁺-monocarboxylate cotransporter
J Physiol
(2004)
V. Coothankandaswamy et al.
The plasma membrane transporter SLC5A8 suppresses tumor progression through depletion of survivin without involving its transport function
Biochem J
(2013)
A. Schaub et al.
PUMA-G, an IFNγ-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily
Eur J Immunol
(2001)
G.A. Cresci et al.
Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8
J Gastrointest Surg
(2010)
H. Tazoe et al.
Roles of short-chain fatty acid receptors GPR41 and GPR43 on colonic functions
J Physiol Pharmacol
(2008)
L.B. Bindels et al.
GPR43/FFA2: physiopathological relevance and therapeutic prospects
Trends Pharmacol Sci
(2013)
M.L. Sleeth et al.
Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation
Nutr Res Rev
(2010)
K.M. Maslowski et al.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Nature
(2009)
A.L. Kau et al.
Human nutrition, the gut microbiome and the immune system
Nature
(2011)

I. Cho et al.

The human microbiome: at the interface of health and disease

Nat Rev Genet

(2012)

C.A. Lozupone et al.

Diversity, stability and resilience of the human gut microbiota

Nature

(2012)

Structure, function and diversity of the healthy human microbiome

Nature

(2012)

Breakthrough of the Year: The Runners-Up. Microbes R Us

Science

(2011)

J.M. Wong et al.

Colonic health: fermentation and short-chain fatty acids

J Clin Gastroenterol

(2006)

C.C. Roy et al.

Short-chain fatty acids: ready for prime time?

Nutr Clin Pract

(2006)

R. Havenaar

Intestinal health functions of colonic microbial metabolites: a review

Benef Microbes

(2011)

J.S. Chen et al.

Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?

Curr Cancer Drug Targets

(2003)

S. Kolida et al.

Synbiotics in health and disease

Annu Rev Food Sci Technol

(2011)

M. Balakrishnan et al.

Prebiotics, probiotics and digestive health

Curr Opin Clin Nutr Metab Care

(2012)

E.M. Quigley

Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults

Nutr Clin Pract

(2012)

H. Li et al.

SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

Proc Natl Acad Sci U S A

(2003)

Cited by (231)

Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women
2024, Translational Oncology
To investigate the vaginal and gut microbes changes during the carcinogenesis of cervical and the auxiliary diagnostic value. To investigate the effect of microbiome-specific metabolites butyric on cervical cancer cells.
We studied 416 vaginal 16S rRNA sequencing data and 116 gut sequencing data. Reads were processed using VSEARCH. We used Shannon index, Chao1 index, Simpson diversity index, β diversity index, Linear discriminant analysis Effect Size (LEfSe), co-abundance network and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis to explore microbiome differences between groups. We constructed random forest models based on genus and verified its discriminant effect. Finally, we used the cell counting kit-8 (CCK-8) method to detect cell proliferation capacity and flow cytometry to detect apoptosis and induction of cell cycle progression.
Compared to the non-cancerous population, patients with cervical cancer had unique microbial community characteristics in both vaginal and gut ecological niches. Our predictive model based on genus in two ecological regions achieved high accuracy in the diagnosis of cervical cancer (vaginal model AUC=91.58 %; gut model AUC=99.95 %). Butyric inhibited cervical cancer cell proliferation in a concentration-dependent manner and promoted apoptosis of cancer cells.
Significant differences were found in vaginal and gut microbes in patients with cervical cancer compared to the non-cancerous population. The prediction models constructed at the genus level in both ecological sites have good diagnostic value. Microorganisms may be involved in cervical cancer progression in a metabolite-dependent way, and targeting butyric may provide therapeutic options for cervical cancer.
Butyrate reduction and HDAC4 increase underlie maternal high fructose-induced metabolic dysfunction in hippocampal astrocytes in female rats
2024, Journal of Nutritional Biochemistry
Maternal nutrient intake influences the health of the offspring via microenvironmental systems in digestion and absorption. Maternal high fructose diet (HFD) impairs hippocampus-dependent memory in adult female rat offspring. However, the underlying mechanisms remain largely unclear. Maternal HFD causes microbiota dysbiosis. In this study, we find that the plasma level of butyrate, a major metabolite of microbiota, is significantly decreased in the adult female maternal HFD offspring. In these rats, GPR43, a butyrate receptor was downregulated in the hippocampus. Moreover, the expressions of mitochondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) were downregulated in the hippocampus. The decreases of these functional proteins were reversed by fructooligosaccharides (FOS, a probiotic) treatment in adulthood. Astrocytes are critical for energy metabolism in the brain. Primary astrocyte culture from female maternal HFD offspring indicated that GPR43 and the mitochondrial biogenesis were significantly suppressed, which was reversed by supplemental butyrate incubation. The oxygen consumption rate (OCR) was reduced in the HFD group and rescued by butyrate. Intriguingly, the nuclear histone deacetylase 4 (HDAC4) was enhanced in the HFD group, suggesting an inhibitory role of butyrate on histone deacetylase activity. Inhibition of HDAC4 effectively restored the OCR, bioenergetics, and biogenesis of mitochondria. Together, these results suggested that the impaired butyrate signaling by maternal HFD could underlie the reduced mitochondrial functions in the hippocampus via HDAC4-mediated epigenetic changes.
Does gut brain axis has an impact on Parkinson's disease (PD)?
2024, Ageing Research Reviews
Parkinson’s Disease (PD) is becoming a growing global concern by being the second most prevalent disease next to Alzheimer’s Disease (AD). Henceforth new exploration is needed in search of new aspects towards the disease mechanism and origin. Evidence from recent studies has clearly stated the role of Gut Microbiota (GM) in the maintenance of the brain and as a root cause of various diseases and disorders including other neurological conditions. In the case of PD, with an unknown etiology, the GM is said to have a larger impact on the disease pathophysiology. Although GM and its metabolites are crucial for maintaining the normal physiology of the host, it is an undeniable fact that there is an influence of GM in the pathophysiology of PD. As such the Enteroendocrine Cells (EECs) in the epithelium of the intestine are one of the significant regulators of the gut-brain axis and act as a communication mediator between the gut and the brain. The communication is established via the molecules of neuroendocrine which are said to have a crucial part in neurological diseases such as AD, PD, and other psychiatry-related disorders. This review is focused on understanding the proper role of GM and EECs in PD. Here, we also focus on some of the metabolites and compounds that can interact with the PD genes causing various dysfunctions in the cell and facilitating the disease conditions using bioinformatical tools. Various mechanisms concerning EECs and PD, their identification, the latest studies, and available current therapies have also been discussed.
Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms
2023, Life Sciences
Depression is one of the common neurological comorbidities in patients with inflammatory bowel disease (IBD). The current study aimed to investigate the potential impact of niacin on colitis-induced depressive-like behavior in rats.
Animals were given 5 % dextran sulfate sodium (DSS) in drinking water for one week to induce colitis. Niacin (80 mg/kg), with or without mepenzolate bromide (GPR109A blocker), was administered once per day throughout the experimental period. Rats were tested for behavioral changes using open field and forced swimming tests.
Niacin significantly ameliorated DSS–induced behavioral deficits and alleviated macroscopic and microscopic colonic inflammatory changes. It also augmented the hippocampal levels of ZO-1, occludin, and claudin-5 proteins, indicating the ability of niacin to restore the blood-brain barrier (BBB) integrity. Moreover, niacin decreased hippocampal IL-1ꞵ and NF-ĸB contents but increased GSH, Sirt-1, Nrf-2, HO-1 concentrations. All these beneficial effects were partially abolished by the co-administration of mepenzolate bromide.
The neuroprotective effect of niacin against DSS-induced depressive-like behavior was partially mediated through GPR109A-mediated mechanisms. Such mechanisms are also involved in modulating neuronal oxidative stress and inflammation via Sirt-1/Nrf-2/HO-1 signaling pathways.
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?
2023, Pharmacology and Therapeutics
Immune checkpoint inhibitors (ICI) have deeply changed the therapeutic management of a broad spectrum of solid tumors. Recent observations showed that obese patients receiving ICIs might have better outcomes than those with normal weight, while obesity was historically associated with a worse prognosis in cancer patients. Of note, obesity is associated with alterations in the gut microbiome profile, which interacts with immune and inflammatory pathways, both at the systemic and intratumoral levels. As the influence of the gut microbiota on the response to ICI has been repeatedly reported, a specific gut microbiome profile in obese cancer patients may be involved in their better response to ICI. This review summarizes recent data on the interactions between obesity, gut microbiota, and ICIs. In addition, we highlight possible pathophysiological mechanisms supporting the hypothesis that gut microbiota could be one of the links between obesity and poor response to ICIs.
The Promise of Niacin in Neurology
2023, Neurotherapeutics
Niacin (vitamin B3) is an essential nutrient that treats pellagra, and prior to the advent of statins, niacin was commonly used to counter dyslipidemia. Recent evidence has posited niacin as a promising therapeutic for several neurological disorders. In this review, we discuss the biochemistry of niacin, including its homeostatic roles in NAD⁺ supplementation and metabolism. Niacin also has roles outside of metabolism, largely through engaging hydroxycarboxylic acid receptor 2 (Hcar2). These receptor-mediated activities of niacin include regulation of immune responses, phagocytosis of myelin debris after demyelination or of amyloid beta in models of Alzheimer's disease, and cholesterol efflux from cells. We describe the neurological disorders in which niacin has been investigated or has been proposed as a candidate medication. These are multiple sclerosis, Alzheimer's disease, Parkinson's disease, glioblastoma and amyotrophic lateral sclerosis. Finally, we explore the proposed mechanisms through which niacin may ameliorate neuropathology. While several questions remain, the prospect of niacin as a therapeutic to alleviate neurological impairment is promising.

View all citing articles on Scopus

View full text

Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host

Highlights

Introduction

Section snippets

SCFAs as bacterial metabolites and their function in the colon

SLC5A8, a plasma membrane transporter, and its relevance to intracellular actions of SCFAs in colonocytes and immune cells

GPR109A, a cell-surface G-protein-coupled receptor, and its relevance to the biologic actions of butyrate in colon

GPR43, a cell-surface G-protein-coupled receptor, and its relevance to the biologic actions of SCFAs

Influence of gut bacteria on the intestinal expression of Slc5a8 and Gpr109a

Dietary fiber content and its relationship to the functions of SLC5A8, GPR109A, and GPR43

Nutritional and pharmacological implications

Conclusions

References and recommended reading

J Biol Chem

J Physiol

Biochem J

Eur J Immunol

J Gastrointest Surg

J Physiol Pharmacol

Trends Pharmacol Sci

Nutr Res Rev

Nature

Human nutrition, the gut microbiome and the immune system

Nature

The human microbiome: at the interface of health and disease

Nat Rev Genet

Diversity, stability and resilience of the human gut microbiota

Nature

Structure, function and diversity of the healthy human microbiome

Nature

Breakthrough of the Year: The Runners-Up. Microbes R Us

Science

Colonic health: fermentation and short-chain fatty acids

J Clin Gastroenterol

Short-chain fatty acids: ready for prime time?

Nutr Clin Pract

Intestinal health functions of colonic microbial metabolites: a review

Benef Microbes

Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?

Curr Cancer Drug Targets

Synbiotics in health and disease

Annu Rev Food Sci Technol

Prebiotics, probiotics and digestive health

Curr Opin Clin Nutr Metab Care

Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults

Nutr Clin Pract

SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

Proc Natl Acad Sci U S A